Handheld Imaging Devices Market, By Type (With Transducer, Without Transducer, Accessories), By Compatibility with Operating System (Android, IOS), By End User (Hospitals, Diagnostic Centres, Point of Care), By Region - Global Analysis Forecast Till 2030

The Global Handheld Imaging Devices market is expected to be worth USD 4.68 billion. The market is expected to grow at a 6.3% CAGR till 2030.

Handheld fluorescence imaging devices are used for diagnostic purposes and have advantages over traditional testing methods in terms of delivering results in a short period. As a result, caregivers and doctors can provide immediate effective treatment and diagnosis to patients with the help of such devices.

Such devices have numerous applications in modern healthcare, including venepuncture, wound healing, etc. Furthermore, this device documents and captures fluorescence information from surrounding tissues and wounds in real-time using still video and images.

Several handheld fluorescence imaging device manufacturers are working to improve the quality of such devices by making them sterilizable and emitting less radiation, resulting in less radiation exposure to surgical staff and patients.

Market Dynamics

Drivers:

When used appropriately, handheld technologies provide benefits over conventional imaging systems, such as enhanced quality of treatment and efficiency. As the diagnosis progresses more quickly, it also helps to lessen emergency department congestion. Throughout the forecast period, these factors are anticipated to propel the handheld imaging devices market.

Restraints:

Handheld imaging devices are not perfect, as they may differ from centralized laboratory tests in some ways. Furthermore, diagnosis with these devices takes less time but may affect the specificity or sensitivity of the results, whereas centralized laboratory tests are extremely sensitive. Another significant challenge of using handheld imaging devices is data storage. According to the National Centre for Biotechnology Information (NCBI), these devices are less useful for diagnosing vascularity (in oncology), ectopic pregnancies, and dealing with obese patients. Over the forecast period, mentioned factors are expected to restrain the global handheld imaging devices market.

Key players:

• Smith & Nephew, Inc.,

• Healcerion, Inc.,

• Micro C, LLC,

• Hunan Ramzed Medical Imaging Technology Co., Ltd.,

• Siemens,

• Koninklijke Philips N.V.,

• Butterfly Network, Inc.,

• BLZ Technology Inc.,

• Kent Imaging INC.

Market Segmentation:

By Type

• With Transducer

• Without Transducer

• Accessories

By Compatibility with the Operating System

• Android

• iOS

By End User

• Hospitals

• Diagnostic Centers

• Point of Care

By Regions

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East

• Africa

Regional Analysis:

North America will have the highest revenue for the handheld fluorescence imaging devices market due to the increased prevalence of breast cancer and the rapid adoption of handheld fluorescence imaging devices in diagnostic procedures, particularly during wound care treatment.

For example, Smith & Nephew, Inc. received FDA approval for the I X handheld fluorescence imaging device for wound management and bacteria detection in December 2019. Following North America, Europe will show robust growth in the handheld fluorescence imaging devices market shortly, owing to improved hospital infrastructure in European countries. The Latin American region will see significant demand for handheld fluorescence imaging devices because of regional government funding for research and development to improve imaging techniques. Due to a lack of hospital infrastructure, the Middle East and Africa are expected to be the least profitable regions for the handheld fluorescence imaging devices market.

Scope of the Report:

User

Tab Content